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Pakistan is fifth among high burden countries for tuberculosis. A steady increase is seen in
extrapulmonary tuberculosis (EPTB), which now accounts for 20% of all notified TB cases.
There is very limited information on the epidemiology of EPTB. This study was performed
with the aim to describe the demographic characteristics, clinical manifestations and treat-
ment outcomes of EPTB patients in Pakistan.
Method
We performed descriptive analysis on routinely collected data for cohorts of TB patients reg-
istered nationwide in 2016 at health facilities selected using stratified convenient sampling.
Findings
Altogether 54092 TB including 15790 (29.2%) EPTB cases were registered in 2016 at 50
study sites. The median age was 24 years for EPTB and 30 years for PTB patients. The
crude prevalence of EPTB in females was 30.5% (95%CI; 29.9–31.0) compared to 27.9%
(95%CI; 27.3–28.4) in males. The likelihood of having EPTB (OR), was 1.1 times greater for
females, 2.0 times for children, and 3.3 times for residents of provinces in the North-West.
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The most common forms of EPTB were pleural (29.6%), lymphatic (22.7%) and abdominal
TB (21.0%). Pleural TB was the most common clinical manifestation in adults (34.2%) and
abdominal TB in children (38.4%). An increase in the prevalence of pleural and osteoarticu-
lar and decline in lymphatic and abdominal TB was observed with advancing age. Diversity
in demography and clinical manifestations were noted between provinces. The treatment
success rate for all type EPTB was significantly high compared to bacteriology confirmed
PTB with the exception of EPTB affecting CNS with a high mortality rate.
Conclusions
The study provides an insight into demography, clinical manifestations and treatment out-
comes of EPTB. Further studies are needed to explain significant diversities observed
between provinces, specific risk factors and challenges concerning EPTB management.
Introduction
Extrapulmonary tuberculosis (EPTB) represents 15% of the incident TB cases notified globally.
The proportion of patients who present with extrapulmonary manifestations varies from 8%
in the WHO Western Pacific region, 17% in South East Asia and 24% in the Eastern Mediter-
ranean Region [1, 2]. There are many forms of extrapulmonary manifestations of TB, affecting
every organ system in the body. Considerable differences are reported in susceptibility to dif-
ferent sites of EPTB by age, race/ethnicity, sex, and country of origin [3, 4, 5]. The proportion
of EPTB among cohort of notified TB cases is reported and monitored every quarter at the
country level and by WHO annually for all member countries, regions and global trends.
Cohort of notified incident TB cases is analyzed for demographic characteristics collectively
for PTB cases and for treatment outcomes, stratified by bacteriology confirmed and clinically
diagnosed TB cases only. However, due to limited data variables used for routine quarterly TB
surveillance reports, stratified cohort analysis for EPTB is not possible [6]. Routine surveillance
data is used by a few, mostly high-income countries to study the epidemiology of EPTB includ-
ing demography, clinical manifestations, bacteriological diagnosis and notification trends [3–
5, 7, 8].
Pakistan is among the top five high burden countries (HBC). Implementation of the DOTS
strategy for TB started in 2001 and within five years expanded to cover most of the public
health sector. National TB control program (NTP) subsequently focused on the expansion of
DOTs coverage in the private health sector, childhood TB and programmatic management of
drug-resistant TB [9, 10]. Regardless, the management of EPTB remained mostly neglected, a
steady increase is seen in absolute numbers of EPTB and proportion among notified TB cases
from 17.4% (45,537) in 2011 to 20% (71,322) in 2016 [1,9]. Diversity is noted in the proportion
of EPTB between provinces. Besides a few hospital-based studies, there is very little informa-
tion on the epidemiology of EPTB disease in Pakistan [11, 12]. We performed a descriptive
analysis on a nationwide sample to determine the demographic characteristics, clinical mani-
festations and treatment outcomes of EPTB patients in Pakistan.
Study design and methodology
Study design
This is a multicenter retrospective observational study, performed on routinely collected data
for cohorts of TB patients registered nationwide in 2016 at health facilities selected using strati-
fied convenient sampling.
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Study setting
Pakistan is a country in South Asia, with an estimated incidence of 510K TB cases and having
a low prevalence of HIV. In 2016, 68% of the estimated TB cases were notified and 20% of
these presented with EPTB [1]. The private health sector including general practitioners (GPs)
engaged in TB care, contributed to 27% of all notified TB cases. By 2016, for TB diagnosis,
microscopy services were established at about 1300 health care facilities (HCF), GeneXpert
(Cepheid, Sunnyvale, CA, USA) at 73 HCF and TB culture in 16 laboratories [1, 10]. Xpert
MTB/RIF (Xpert) testing is recommended for the diagnosis of EPTB since 2013 [1, 13] but TB
culture facilities are offered mostly for drug-resistant TB patients. Histopathology services
although limited to tertiary hospitals in public sector but are offered widely by commercial
clinical laboratories.
Standard recording and reporting tools are used [6] and data of each notified TB patient is
recorded in TB registers at each HCF. A separate TB register is maintained at district level for
recording TB cases notified by GPs. Although there are no specific columns in TB registers for
recording EPTB disease site or laboratory test results other than bacteriology but the staff is
generally guided to record these details in a column for remarks.
Pakistan is administratively divided into four provinces; Punjab (PJB), Sindh (SND), Khy-
ber Pakhtunkhwa (KP) and Balochistan (BTN), three regions namely Federally administered
tribal area (FATA), Gilgit Baltistan (GB), and Azad Jammu Kashmir (AJK) and Islamabad cap-
ital territory (ICT). FATA districts were merged into KP province in 2019. SND and PJB are
large provinces comprising >70% of the total country population and geographically located
in South-East, whereas KP, FATA, BTN, and GB are in North-West of the country (S1 Fig).
Data source and collection
We used TB registers with records of TB patients notified in 2016 for the study. For data col-
lection, HCFs were selected using stratified convenient sampling. Separate lists were first
obtained of HCFs in each province and region along with the numbers of PTB and EPTB cases
notified by each in 2016. HCFs were than stratified into Level-I (Primary HCF/clinics), Level-
II (secondary HCF/specialized TB hospitals) and Level-III (tertiary hospitals). Based on EPTB
case notification, a shortlist was prepared by selecting the top five HCF/ tier for each province
and three/ tier for the region. This list was then handed over to the respective TB program for
data collection with guidance to further select from this list two HCFs/tier/province and one
HCF/tier/ region, based on the quality and completeness of the data recorded in the TB regis-
ters. Data collection was started in 2018 and all HCF staff was guided to check for data com-
pleteness and to record missing data before making copies of the TB registers.
For a sampling of TB cases notified by private GPs, the two implementing partners working
respectively in 13 and 79 districts were asked to provide a copy of the district TB registers. Pri-
vate GP clinics were classified as level-I HCF.
Data management
TB registers were received at NTP office Islamabad. A specially designed electronic file, (devel-
oped in EpiData Manager V4.4.2.1) was used for data entry. Case-based data was entered
(through EpiData Entry Client v4.4.3.1, EpiData Association, Odense, Denmark) for variables
including age, sex, history of TB treatment, disease site, laboratory results and treatment out-
comes. All TB cases registered between 1st January and 31st December 2016 were included in
the study. After entry, data was checked for completeness and if for any HCF, EPTB disease
sites recorded were less than 80% of the registered cases, respective TB program was requested
again to collect missing information where possible.
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Standard definitions were used for defining children (0-14yrs), adult (�15yrs), new, previ-
ously treated, bacteriology confirmed (B+) and clinically diagnosed TB cases based on data
recorded in the TB registers [6]. Cases were categorized by major disease sites, reported as
either PTB or EPTB. The PTB group comprised cases with PTB listed as the only disease site.
The EPTB cases were grouped according to extrapulmonary disease site: pleural, lymphatic
intra-thoracic, lymphatic extra-thoracic, osteoarticular spine and osteoarticular other than the
spine, the central nervous system including meninges, abdominal including peritoneal and
disseminated TB including miliary. Extrapulmonary manifestations if specified other than
sites mentioned above were listed as “others” and if not specified were listed as EPTB not spec-
ified (NOS).
Data were analyzed using STATA1 v13.1 (StataCorp, 4905 Lakeway Drive, College Station,
Texas 77845, USA). Logistic regression was performed to calculate odds ratios (OR) and 95%
confidence intervals for comparisons between groups, while mean, median and quartiles were
analyzed for quantitative variables. Two sample proportion test was used to analyze differences
in proportions between groups. A p-value of p<0.05 was considered statistically significant.
Ethics statement: For confidentiality, patient identifiers were not entered into the database
used for the study. The study protocol was approved by the ‘‘Institution review board” of HIV,
TB and malaria programs, Islamabad, Pakistan and Regional Committee for Medical and
Health Research Ethics, Western-Norway (REK Vest).
Results
Altogether 50 TB registers were collected including 37 HCF (35 public and 2 private) and 13
district TB registers. Only one implementing partner provided records of TB patients notified
by GPs in 13 districts. The study population covered 32 districts and included samples from all
four provinces, three regions, and federal capital. Study sites included 29 level-I (16 public, 13
district GP clusters), 11 level-II (all public) and 10 level-III HCF (8 public, 2 private). Details of
study sites are shown in S1 and S2 Tables.
Reported tuberculosis cases
Altogether 54,092 TB including 38,302 PTB and 15,790 EPTB (29.2%) patients were registered
at selected 50 study sites in 2016. Of all TB cases notified country wide in 2016, the proportion
included in the study sample from each province/region is shown in S2 Table. Twenty one TB
cases were recorded having concurrent EPTB and PTB and these were counted with EPTB
cohort. Age was missing for 22 TB including three EPTB patients. The disease site was not
specified for 1399 EPTB cases (8.5%). Treatment outcome was not recorded for 3222 TB
(7.0%) including 694 EPTB (4.9%) patients.
The characteristics of PTB and EPTB patients included in the study are shown in Table 1.
Demographic characteristics
The median age of patients with EPTB was 24yrs compared to 30yrs for PTB. Overall 52.4% of
EPTB and 49.2% of PTB patients were females. Peak TB notification was seen in the age group
of 15-24yrs (26.6%) with females being in the clear majority among both PTB (F: M 1.4:1) and
EPTB patients (F:M 1.4:1). A decline in female TB notifications was observed with increasing
age (Fig 1).
The crude prevalence of EPTB in females was 30.5% (95%CI; 29.9–31.0) compared to
27.9% (95%CI; 27.3–28.4) in males. Compared to the total study sample, the proportion of
EPTB was higher among TB patients notified in North-West provinces/regions (BTN, KP,
FATA, AJK) and ICT and are shown in Table 2 and S2 Table.
PLOS ONE Extrapulmonary tuberculosis in Pakistan
PLOS ONE | https://doi.org/10.1371/journal.pone.0232134 April 28, 2020 4 / 16
The odds of patients presenting with EPTB, compared with PTB, were 1.1 times as high for
females, 2.0 times for children, 3.0 times for residents of KP and FATA and 2.0 times for BTN
and ICT compared to PJB. Female to male ratio (FMR) and age-specific female likelihood to
present with EPTB in each province /region is shown in Table 2 and S3 Table. A higher odds
(OR = 1.3) for EPTB were reported among females in the age group of 25-34yrs and among
residents of SND province (Fig 1 and S3 Table). No differences were observed in the likelihood
of female presenting with EPTB seeking health care from the public (OR = 1.14, 95% CI: 1.08–
1.19) compared to private sector (OR = 1.18, 95% CI: 1.11–1.24). Overall, 15.4% (8338) of all
Table 1. Characteristics of patients having extrapulmonary compared to pulmonary tuberculosis notified by
study sites in 2016.
Pulmonary TB n(%) Extra pulmonary PTB n(%) OR (95% CI)
TB cases notified 38302 15790
Median Age (IQR) 30(19,50) 24(15,39)
Sex
Male 19455(50.8) 7519(47.6) Ref
Female 18847(49.2) 8271(52.4) 1.1 (1.1–1.2)
Age Group�
0–14 4731(12.4) 3607(22.8) 1.69(1.60–1.79)
15–24 9932(25.9) 4474(28.3) Ref
25–34 6474(16.9) 2874(18.2) 0.99 (0.93–1.04)
35–44 4720(12.3) 1649(10.4) 0.78 (0.73–0.83)
45–54 4946((12.9) 1351(8.6) 0.61 (0.57–0.65)
55–64 4075(10.6) 958(6.1) 0.52 (0.48–0.56)
65+ 3405(8.9) 874(5.5) 0.57 (0.52–0.62)
Place of origin
PJB 17950(46.9) 5580(35.3) Ref
SND 12294(32.1) 3514(22.3) 0.9 (0.9–1.0)
KP 3872(10.1) 3930(24.9) 3.3 (3.1–3.4)
BTN 1310(3.4) 801(5.1) 2.0 (1.8–2.1)
FATA 466(1.2) 472(3.0) 3.3 (2.9–3.7)
GB 1256(3.3) 437(2.8) 1.1 (1.0–1.2)
AJK 577(1.5) 347(2.2) 1.9 (1.7–2.2)
ICT 577(1.5) 709(4.5) 4.0 (3.5–4.4)
Previous TB treatment
No 34235(89.4) 15072(95.4) Ref
Yes 3894(10.2) 627(4.0) 0.4(0.3–0.4)
NA 173(0.5) 91(0.6) 1.2(1.0–1.5)
Health Care Provider
Public 16684(43.6) 9206(58.3) Ref
Private 21618(56.4) 6584(41.7) 0.5(0.5–0.6)
Health Care facility Level
PHC(All) 16800(43.6) 6128(38.8) Ref
SHC 9950(26.0) 4687(29.7) 1.3 (1.2–1.4)
TCH 11552(30.2) 4975(31.5) 1.2 (1.1–1.3)
PJB-Punjab, SND-Sindh, KP-Khyber Pakhtunkhwa, BTN-Balochistan, AJK-Azad Jammu Kashmir, GB-Gilgit
Baltistan, FATA-federally administered tribal areas, ICT-Islamabad Capital territories. PHC-Primary health care,
SHC-secondary health care facility, TCH-Tertiary care hospital
� 22 cases with missing records for age excluded from this analysis
https://doi.org/10.1371/journal.pone.0232134.t001
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TB, 22.8% (3607) of EPTB and 12.4% (4731) of PTB patient were children (Table 1). More
than 40% of EPTB patients in BTN, KP, FATA, and GB were children compared to around
10% in PJB, SND, and AJK. The crude prevalence of EPTB in children was 43.3% and was
highest compared to all other age groups. A decline in the proportion of EPTB was observed
with increasing age (Table 3). A similar pattern was observed across all province/regions
with the exception of SND having the highest proportion of EPTB among 15-34yrs (S4A–
S4H Table).
Extrapulmonary manifestations
The median age was youngest (17yrs) for patients with abdominal TB and oldest (34yrs) for
patient with osteoarticular TB other than spine. The site-specific median age for the cohort of
EPTB patients studied is shown in Table 3 and S4A–S4H Table.
Among all EPTB patients (15790), frequency of different manifestations were, pleural
(29.6%), lymphatic (22.6%), abdominal (21.0%), osteoarticular (9.4%), central nervous system
(CNS) (4.6%), other (3.7%) and disseminated TB (0.6%). The EPTB disease site was not
recorded in 8.5% of patients. Frequency of different EPTB disease forms in children (3607)
compared to adults (12180) were, abdominal (38.4% vs 15.8%), lymphatic (22.4% vs 22.7%),
pleural (14.0% vs 34.2%), osteoarticular (3.9% vs 11.0%), CNS (6.0% vs 4.2%) and not specified
(12.1 vs 7.4%) (Table 3).
Fig 1. Age and sex-specific pulmonary and extrapulmonary tuberculosis case notifications and age-specific odds of female for having
extrapulmonary tuberculosis. PTB-M; Male pulmonary tuberculosis patients, PTB-M- Female pulmonary tuberculosis patients, EPTB-F, Female
extrapulmonary tuberculosis patients, EPTB-M, Male extrapulmonary tuberculosis patients, F: M-OR: Female to male odds ratio for EPTB. TB cases
notified are shown on the primary axis and OR on the secondary axis.
https://doi.org/10.1371/journal.pone.0232134.g001
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Among all ages, notification of pleural TB compared to abdominal TB was significantly
higher (P< .001) in South Eastern provinces, PJB (36.2 vs12.0%), SND (33.9 vs 17.1%) and
AJK (39.2 vs 16.4%) whereas, abdominal TB was more common (P< .001) in North West
provinces including KP (34.4 vs 23.4%), FATA (49.8 vs 22.0) and GB (46 vs10.1%) (Table 3
and S4A–S4H Table).
Among adult population, pleural TB was the commonest form (range 16.9–55.6%) across
all provinces/regions. However the second commonest was lymphatic TB in PJB, SND, GB
and ICT (21.3–26.7%), compared to abdominal TB in KP, BTN and FATA (range 15.3–
25.3%). Among children the most commonly reported extrapulmonary manifestation was
lymphatic TB in PJB, SND and AJK (>40%), abdominal TB in KP (44%), FATA and GB
(>70%) and meningitis (33%) in BTN (S4A–S4H Table).
A steady decline in lymphatic and abdominal TB and an increase in pleural and osteoarticu-
lar TB was observed with advancing age (Table 3 and Fig 2).
Lymphatic TB was significantly more common in females (26.6 vs 18.4%, P< .001). A
higher number of females were observed within each EPTB disease form, with the exception
of pleural TB which was more common in males (34.5 vs 25.1%, P< .001) (Table 3).
Bacteriological diagnosis
Results of AFB smear and/or Xpert were recorded for 86.1% PTB and 8.8% EPTB patients.
Among notified cases, 49.3% of PTB (18872) and 0.55% (87) EPTB patients were bacteriology
confirmed. Culture and/or histopathology results were not recorded in the TB register.
Table 2. Pulmonary and extrapulmonary tuberculosis case notified, female to male ratio and odds of female for having extrapulmonary TB.
Pakistan PJB SND KP BTN FATA GB AJK ICT
All form TB All 54092 23530 15808 7802 2111 938 1693 924 1286
Female 27118 (50.1%) 11759(50.0%) 7746(49.0%) 4026(51.6%) 1149(54.4%) 440(46.9%) 952(56.2%) 466(50.4%) 580(45.1%)
Male 26974(49.9%) 11771(50.0%) 8062(51.0%) 3776(48.4%) 962(45.6%) 498(53.1%) 741(43.8%) 458(49.6%) 706(54.9%)
FMR 1.0 1.0 1.0 1.1 1.2 0.9 1.3 1.0 0.8
PTB All 38302 17950 12294 3872 1310 466 1256 577 577
Female 18847(49.2%) 8819(49.1%) 5763(46.9%) 2044(52.8%) 734(56.0%) 234(50.2%) 707(56.3%) 302(52.3%) 244(42.3%)
Male 19455(50.8%) 9131(50.9%) 6531(53.1%) 1828(47.2%) 576(44.0%) 232(49.8%) 549(43.7%) 275(47.7%) 333(57.7%)
FMR 1.0 1.0 0.9 1.1 1.3 1.0 1.3 1.1 0.7
EPTB ALL 15790 5580 3514 3930 801 472 437 347 709
Female 8271(52.4%) 2940(52.7%) 1983(56.4%) 1982(50.4%) 415(51.8%) 206(43.6%) 245(56.1%) 164(47.3%) 336(47.4%)
Male 7519(47.6%) 2640(47.3%) 1531(43.6%) 1948(49.6%) 386(48.2%) 266(56.4%) 192(43.9%) 183(52.7%) 373(52.6%)











































































PJB-Punjab, SND-Sindh, KP-Khyber Pakhtunkhwa, BTN-Balochistan, AJK- Azad Jammu Kashmir, GB-Gilgit Baltistan, FATA-Federally administered tribal areas,
ICT-Islamabad Capital territories, FMR-Female to male ratio, PTB-Pulmonary tuberculosis EPTB-extrapulmonary tuberculosis, FM OR-Female to male odds ratio
https://doi.org/10.1371/journal.pone.0232134.t002
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Treatment outcomes
Overall treatment success for EPTB cases was higher compared to both bacteriology confirmed
and clinically diagnosed PTB. The treatment success was close to 90% for people having pleu-
ral, lymphatic and abdominal TB. Treatment success was significantly lower (P< .001) for
patients with TB meningitis compared to other forms (Table 4).
Table 3. Extrapulmonary manifestation of tuberculosis by sex, age group and place of residence among the cohort of TB patients.








































419(5.6) 278(3.7) 360((4.8) 49(0.7) 261(3.5) 7519 26,974 27.9%









70(1.6) 795(17.8) 182(4.1) 148(3.3) 182(4.1) 35(0.8) 154(3.4) 4,474 14,406 31.1%
25–34 214(7.4) 905(31.5) 681(23.7) 27(0.9) 488(17.0) 202(7.0) 108(3.8) 94(3.3) 11(0.4) 144(5.0) 2,874 9,348 30.7%
35–44 129(7.8) 546(33.1) 336(20.4) 18(1.1) 250(15.2) 145(8.8) 75(4.5) 60(3.6) 14(0.8) 76(4.6) 1,649 6,369 25.9%
45–54 110(8.1) 493(36.5) 227(16.8) 10(0.7) 180(13.3) 123(9.1) 88(6.5) 58(4.3) 9(0.7) 53(3.9) 1,351 6,297 21.5%
55–64 63(6.6) 397(41.4) 128(13.4) 9(0.9) 115(12.0) 98(10.2) 51(5.3) 55(5.7) 4(0.4) 38(4.0) 958 5,033 19.0%
65+ 52(5.9) 400(45.8) 108(12.4) 6(0.7) 98(11.2) 86(9.8) 36(4.1) 58(6.6) 9(1.0) 21(2.4) 874 4,279 20.4%
All�15yrs 902(7.4) 4164
(34.2)






86(1.5) 672(12.0) 291(5.2) 288(5.2) 200(3.6) 10(0.2) 246(4.4) 5580 23530 23.7%
SND 101(2.9) 1190
(33.9)
1002(28.5) 32(0.9) 602(17.1) 272(7.7) 94(2.7) 80(2.3) 21(0.6) 120(3.4) 3514 15808 22.2%
KP 454
(11.6)
918(23.4) 635(16.2) 57(1.5) 1350(34.4) 163(4.1) 101(2.6) 90(2.3) 30(0.8) 132(3.4) 3930 7802 50.4%
BTN 204
(25.5)
83(10.4) 59(7.4) 5(0.6) 124(15.5) 56(7.0) 37(4.6) 205
(25.6)
12(1.5) 16(2.0) 801 2111 37.9%
FATA 7(1.5) 104(22.0) 47(10.0) (0.0) 235((49.8) 24((5.1) 8(1.7) 19(4.0) 1((0.2) 27(5.7) 472 938 50.3%
GB 5(1.1) 44(10.1) 105(24.0) (0.0) 201(46.0) 31(7.1) 25(5.7) 13(3.0) 3(0.7) 10(2.3) 437 1693 25.8%
AJK 9(2.6) 136(39.2) 65(18.7) 1(0.3) 57(16.4) 26(7.5) 12(3.5) 13(3.7) 5(1.4) 23(6.6) 347 924 37.6%
ICT 96(13.5) 174(24.5) 182(25.7) (0.0) 72(10.2) 47((6.6) 8(1.1) 105
(14.8)
12(1.7) 13(1.8) 709 1286 55.1%
EPTB-Extrapulmonary TB, Site-NOS-EPTB site not specified, LN-EXT-lymphatic extra-thoracic, LN-INT-Lymphatic intrathoracic, OAS-Osteoarticular spine, OAOS-
Osteoarticular other than the spine, CNS-Central Nervous system, Dis/Mil–Disseminated /Miliary TB. PJB-Punjab, SND-Sindh, KP-Khyber Pakhtunkhwa,
BTN-Balochistan, AJK-Azad Jammu Kashmir, GB-Gilgit Baltistan, FATA-Federally administered tribal areas, ICT-Islamabad Capital territories.
� Age was missing from 22 records including 3 EPTB patients
https://doi.org/10.1371/journal.pone.0232134.t003
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Discussion
To our knowledge, this is the first multicenter study where routine TB program data is used
to describe demographic characteristics, clinical manifestations and treatment outcomes of
EPTB patients in Pakistan. We performed a record review of 54,092 TB patients including
15,790 EPTB cases, notified in 2016 by HCF conveniently selected from all tiers of health care
covering all provinces/regions in the country. The study population comprised 21.6% of EPTB
and 13.1% of PTB cases notified countrywide in 2016. We purposefully went for oversampling
of EPTB to include jurisdictions that appeared to be particularly sensitized to the issue and
potentially would provide complete records to study a wider spectrum of EPTB manifestations.
There was thus a higher proportion of EPTB in the study sample (29%) compared to national
notification (20%) in the same year [1].
The variations in proportion of EPTB among TB cases notified in different provinces/
regions is already observed in routine TB notification data. Proportion of EPTB in countries
neighboring Pakistan, varies from 5% in China (HBC), 18% in India (HBC), 25% in Iran and
29% in Afghanistan [2]. Interestingly compared to national average, proportion of EPTB is
higher in provinces/regions in the North West (KP, FATA, BTN) neighboring Afghanistan
and Iran and a relative lower in proportion in the South East provinces (PJB &SND) neighbor-
ing India. In TB population studied, proportion of EPTB although was higher but provincial
ranking was consistent with national notification trend. There are some evidences suggesting
that PTB incidence decreases as geographical altitude increases [14–18] without effect on
EPTB incidence [18]. In Pakistan, provinces and regions in North West with higher propor-
tion of EPTB among notified TB cases, show a trend of lower PTB case notification rate
Fig 2. Frequency of different extrapulmonary manifestations by age group. NOS: EPTB site not specified, LN-lymphatic, Abd-abdomen;
OAS-Osteoarticular, CNS-Central Nervous system, Dis/mil-Disseminated /Miliary.
https://doi.org/10.1371/journal.pone.0232134.g002
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compared to national average (S2 Table). However, differences in notifications of PTB and
EPTB cannot be explained based on this correlation alone and further studies including sub
national surveys are needed to determine prevalence of TB, coverage and accessibility to health
care services, health seeking behaviors of patients with extrapulmonary manifestations com-
pared to pulmonary symptoms and practices of doctors managing EPTB in different geograph-
ical settings.
In total study population, male and female were equal in number but differences were
observed in gender distribution both among PTB and EPTB cases notified in different prov-
inces. Similar to the global trends higher number of male among PTB cases and higher odds
of female presenting with EPTB was seen in residents of South-Eastern provinces (SND, PJB)
and ICT.[1–5,7,8] In contrast, a higher female to male ratio was seen among PTB patients
from North-Western provinces (KP, BTN), consistent with trend seen in routine notification
[19,20] and similar to the pattern in bordering Afghanistan [2]. However likelihood of both
sexes presenting with EPTB manifestations was similar in these regions (BTN, KP, FATA, and
AJK). Differences in the relative frequency of EPTB by sex, race, ethnicity, and provenance
have been reported by others [3–5, 8, 21–23]. Gender differences in notification rates are
known to reflect differences in TB epidemiology, and/or gender differences in access to care
[24]. In Pakistan, based on TB prevalence survey findings, it is estimated that males have 1.8
times higher burden of PTB [1,2,25] but gender differences are minimal among notified TB
cases and prevalence to notification ratio clearly explains gaps in case detection of PTB in
males. However as opposed to PTB, the true burden and gaps in detection of EPTB cannot be
determined objectively as EPTB is typically excluded from the measurement of prevalence [2].
Regardless, variation in case notification rates between provinces, similarity was seen in adult
case notification pattern, with higher number of females among notified PTB and EPTB
Table 4. Treatment outcomes of patients having bacteriology confirmed pulmonary tuberculosis, clinically diagnosed pulmonary tuberculosis and extrapulmonary
tuberculosis.
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https://doi.org/10.1371/journal.pone.0232134.t004
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patients in age group of 15-34yr, which was similar to the PTB notifications pattern reported
in Europe in middle of last century.[24]. Pakistan has one of the highest levels of child and
maternal under nutrition worldwide and large social and geographical inequalities are noted
in child and maternal nutrition [26,27]. According to WHO estimates approximately 150,000
incident TB cases in Pakistan are associated with malnutrition [2]. Further studies are needed
to establish evidence based linkages between TB in young females to poverty, under nutrition,
sex-specific social and biological characteristics.
Consistent with other studies, we reported a strong association between EPTB and children,
[3, 4, 8] with EPTB affecting children twice as frequently as adults (OR = 2.0). The most
intriguing finding was high proportion of children (n = 1385, 38.4%) having abdominal TB
and more than 80% of these children belonged to provinces in North-West (KP, FATA, and
GB). Beside children, higher rates of abdominal TB was also reported in adult TB patients
from KP and FATA. While surveillance data analysis of EPTB patients from high income
countries have reported low prevalence (<5%) of abdominal TB [3,4, 8], but prevalence vary-
ing from 6.8% (Afghanistan), 12.8% (India), 14.8% (Nepal), 15.4% (Australia) and 17.5%
(Saudi Arabia) are reported mostly in hospital-based small studies [28–32]. The drivers of TB
in children including the high levels of chronic and acute malnutrition do still exist in Paki-
stan, with over 10 million stunted children [27]. The malnutrition alone, however, does not
explain the higher prevalence of abdominal TB among children in the North-West regions as a
higher prevalence of stunting (> national average of 40.2%) is also reported in SND in the
South. There is a need to study high rates of abdominal TB in children and in particular clini-
cal criteria used for diagnosis and prevailing empiric TB treatment practices.
Consistent with trend reported in other countries, the two most common extrapulmonary
manifestations reported in our study population were pleural and lymphatic, collectively mak-
ing 50% of all EPTB cases [3–5, 7, 8, 21, 22, 28–32]. Similarity in frequency of different EPTB
manifestations was noted in adult population, with pleural TB being the most common across
all provinces/regions. Although lymphatic TB was the second commonest form, but only a
very few patients (1%) were reported having intra-thoracic lymphatic TB. Contrary to our
findings, high predilection for intra-thoracic lymphatic TB in young ages is reported by others
[3, 4]. Likely reasons for under reporting in our settings include lack of training and/or access
to radiology facilities or under-recording of findings in TB registers.
We reported osteoarticular TB in 9.3% (1483) of EPTB patients and spinal TB was noted to
be more common compared to other forms of bones/joint TB. The median ages of patients
with osteoarticular TB was higher compared to all other forms of EPTB. Our findings are con-
sistent with prevalence reported in high income countries [3, 4, 5, 7] but prevalence is lower
compared to Benin (25.4%) and Ghana (17.5%) [8, 33].
Among EPTB patients in our study, 6.0% of children and 4.2% adults were reported having
CNS TB, frequency was higher compared to high-income countries [3,4,7] but lower than
reported by studies in low income and high HIV prevalence countries [8,33]. Among ten ter-
tiary care hospital included in our study, with the exception of three, proportion of CNS TB
reported by each was lower than total average. Based on these findings, possibility of reporting
a higher prevalence of CNS TB due to selection bias can be argued, nevertheless it does indi-
cates serious gaps in notifications and weak linkages between reporting units and other spe-
cialties treating CNS TB in tertiary care settings. Beside weak linkages, other possible reasons
for underreporting includes patients with serious forms of TB dying before reaching HCF or
dying undiagnosed in hospitals.
We reported a low frequency of “other” group of EPTB manifestations including genitouri-
nary tuberculosis (3.7%) in population studied. Although possibility of underreporting cannot
be excluded, but our findings are consistent with reports from high income countries, where a
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relative higher predilection of genitourinary tuberculosis is reported in whites compared to
non-whites. [3, 5, 23]
EPTB disease site was not recorded in 8.5% of patients included in the study. In TB-bur-
dened countries EPTB is one of the important causes of fever of unknown origin [34]. In TB
registers where disease site was recorded for majority of the notified EPTB cases, one plausible
explanation for missing details is, that these patients were most likely initiated on empiric TB
treatment for fever of unknown origin without further investigations either due to lack of diag-
nostic facilities or resources.
Of all EPTB cases included in the study, a high majority of the patients were successfully
treated consistent with findings from other studies [4, 8]. Proportion of patients with history
of previous treatment was low in EPTB (4.0%) compared to PTB (10.2%) cohort, which
most likely was one of the reasons for a higher treatment success rate compared to PTB.
However treatment outcomes are usually reported, using standard classifications; and
‘‘treatment completion” is considered a successful outcome [6, 8]. Possibilities cannot be
excluded of reporting treatment completion for patients without clinical improvement par-
ticularly in case of undiagnosed drug resistance or disease other than EPTB, as well as for
patient with clinical improvement who were initiated on empiric TB treatment for trivial
nonspecific infection.
Furthermore, treatment outcomes of different non-pulmonary manifestations of TB cannot
be lumped together as if they are a single entity [3]. Treatment success rate were higher for
pleural, lymphatic and abdominal TB (90%), but was significantly lower for CNS TB (74.3%,
95%CI 71.0–77.5%). Reported mortality in patients with CNS TB was 4.4% but more than 15%
were reported lost to follow up with possibility of underreporting of mortality rate. The poor
outcome of CNS TB and other severe forms of TB are masked by the overall high treatment
success and are thus ignored.
EPTB can affect any part of the body, and due to the heterogeneity in clinical manifesta-
tions, and difficulties in obtaining specimens, the definite diagnosis can be especially chal-
lenging. In high-income countries, 50–60% of the notified EPTB cases are bacteriology
confirmed [3, 5, 8, 32]. On the contrary, in our study, less than 10% of patient were tested
and only 0.5% of the notified EPTB cases were bacteriology confirmed, similar to reports
from other low income countries [8]. Besides lack of resources and access to specialized
facilities, likely reasons for reliance on clinical diagnosis, includes low sensitivity of widely
available AFB microscopy, limited access and complexity associated with TB culture test-
ing and lack of surveillance for EPTB. Possibilities of over and under-diagnosis of EPTB
cannot be excluded in these scenarios. EPTB in general is not given high priority on the
public health agenda, probably as it does not contribute significantly to the transmission
of the disease [4]. With availability of simpler, more sensitive molecular diagnostics [35]
there is need for systematic efforts to increase testing of all EPTB specimens for definite
diagnosis of TB and drug resistance. This can be achieved by a more decentralized access
to new diagnostic tools, multidisciplinary engagements with effective linkages, clear guid-
ance on diagnosis and management of EPTB, capacity enhancement of clinical and labora-
tory staff and finally comprehensive surveillance system to monitor EPTB notifications in
real time.
The main limitations of our study includes use of stratified convenient sampling and volun-
tary data collection, which makes it quite possible that our findings are not completely repre-
sentative of the entire country. Secondly, routine clinical records were used with possible
multiple problems in the information recorded. Third, almost all of the notified EPTB cases
were clinically diagnosed with possibilities of different protocols being used for diagnosis
across country.
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Conclusion
The study provides an insight into the demography, prevalent clinical manifestations and
treatment outcomes of EPTB. Further studies are needed to explain significant differences
observed between provinces and associated specific risk factors. From a public health perspec-
tive, there is a need to focus on EPTB accounting 20% of the TB disease burden, and address
challenges concerning the quality of diagnosis and treatment of patients presenting with extra-
pulmonary manifestations of TB.
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age groups and health facilities in Azad Jammu & Kashmir, Pakistan, during 2016 EPTB–Extra
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LN-INT-Lymphatic intra thoracic, ABD-Abdomen, OAS–Osteoarticular spine, OAOS-Os-
teoarticular other than spine,CNS-Central nervous system, DIS/MIL–Disseminated /Miliary
TB. H: Notified tuberculosis cases and extrapulmonary manifestations of tuberculosis by sex,
age groups and health facilities in Islamabad capital Territory, Pakistan during 2016 EPTB–
Extra pulmonary tuberculosis, Site-NOS: EPTB site not specified, LN-EXT-lymphatic extra-
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